These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26228833)

  • 1. The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions.
    Pasterk L; Philipose S; Eller K; Marsche G; Heinemann A; Schuligoi R
    Pharmacology; 2015; 96(3-4):137-43. PubMed ID: 26228833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation.
    Philipose S; Konya V; Sreckovic I; Marsche G; Lippe IT; Peskar BA; Heinemann A; Schuligoi R
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2416-23. PubMed ID: 21071691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors.
    Petrucci G; De Cristofaro R; Rutella S; Ranelletti FO; Pocaterra D; Lancellotti S; Habib A; Patrono C; Rocca B
    J Pharmacol Exp Ther; 2011 Feb; 336(2):391-402. PubMed ID: 21059804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EP1/EP3 receptor agonist 17-pt-PGE
    Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
    Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
    Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function.
    Iyú D; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
    Platelets; 2010; 21(5):329-42. PubMed ID: 20433310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS; Jones RL
    Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole blood.
    Schober LJ; Khandoga AL; Dwivedi S; Penz SM; Maruyama T; Brandl R; Siess W
    J Thromb Thrombolysis; 2011 Aug; 32(2):158-66. PubMed ID: 21424266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptors.
    Glenn JR; White AE; Iyu D; Heptinstall S
    Platelets; 2012; 23(5):344-51. PubMed ID: 22436052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
    Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
    Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence.
    Tilly P; Charles AL; Ludwig S; Slimani F; Gross S; Meilhac O; Geny B; Stefansson K; Gurney ME; Fabre JE
    Cardiovasc Res; 2014 Mar; 101(3):482-91. PubMed ID: 24323317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
    Heptinstall S; Espinosa DI; Manolopoulos P; Glenn JR; White AE; Johnson A; Dovlatova N; Fox SC; May JA; Hermann D; Magnusson O; Stefansson K; Hartman D; Gurney M
    Platelets; 2008 Dec; 19(8):605-13. PubMed ID: 19012178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice.
    Kashiwagi H; Yuhki KI; Imamichi Y; Kojima F; Kumei S; Tasaki Y; Narumiya S; Ushikubi F
    Thromb Haemost; 2019 Aug; 119(8):1311-1320. PubMed ID: 31129913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EP3-agonist sulprostone, but not prostaglandin E2 potentiates platelet aggregation in human blood.
    Schober LJ; Khandoga AL; Penz SM; Siess W
    Thromb Haemost; 2010 Jun; 103(6):1268-9. PubMed ID: 20431854
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostanoid EP3 receptor agonist sulprostone enhances pacemaker activity of colonic interstitial cells of Cajal.
    Kim MW; Jiao HY; Kim SW; Park CG; Wu MJ; Hong C; Choi S; Jun JY
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):961-969. PubMed ID: 28685234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGE2 decreases reactivity of human platelets by activating EP2 and EP4.
    Smith JP; Haddad EV; Downey JD; Breyer RM; Boutaud O
    Thromb Res; 2010 Jul; 126(1):e23-9. PubMed ID: 20451959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes.
    Konger RL; Malaviya R; Pentland AP
    Biochim Biophys Acta; 1998 Feb; 1401(2):221-34. PubMed ID: 9531979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts.
    Sarrazin P; Hackett JA; Fortier I; Gallant MA; de Brum-Fernandes A
    J Rheumatol; 2004 Aug; 31(8):1598-606. PubMed ID: 15290741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 both stimulates and inhibits adenyl cyclase on platelets: comparison of effects on cloned EP4 and EP3 prostaglandin receptor subtypes.
    Mao GF; Jin JG; Bastepe M; Ortiz-Vega S; Ashby B
    Prostaglandins; 1996 Sep; 52(3):175-85. PubMed ID: 8908618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.